Ajanta receives USFDA approval for Irbesartan (75, 150 and 300mg). Used for treating hypertension and nephropathy in type II diabetic patients.
http://www.accessdata.fda.gov/scripts/cder/ob/docs/obdetail.cfm?Appl_No=203685&TABLE1=OB_Rx
The total market size for Irbesartan tablets as per IMS is ~$50 million per annum.
Sanofi, Ajanta, Alembic, Apotex, Auro, Cipla, DRL, Hetero Jubilant, Lupin, MacLeods, Mylan, Prinston, Roxane, Sandoz, Sciegen, Teva, Unichem, Watson, Zydus have Irbesartan approval.
| Subscribe To Our Free Newsletter |
